Exploring the therapeutic potential of Spirulina platensis in polycystic ovarian syndrome: A computational pharmacology approach
In Silico Research in Biomedicine · 2026 · 2 · 100240
DOI: 10.1016/j.insi.2026.100240 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Research in Biomedicine, 2026. Verfasst von Vaishnavi Gabhane und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
To explore the mechanism of action of Spirulina platensis for its therapeutic role in polycystic ovarian syndrome. The well-known dietary supplement spirulina (SP) has anti-inflammatory, antioxidant, and metabolic-regulating qualities. The widespread endocrine condition is termed polycystic ovarian syndrome (PCOS), characterized by metabolic imbalance, inflammation, and oxidative stress.
Objective
To explore the potential of Spirulina platensis in PCOS using network pharmacology and molecular docking.
Method
Using bioinformatics to build a compound-gene network, this study found four bioactive substances, ascorbic acid, niacin, riboflavin, and thiamine, connected to SP's ability to treat PCOS. Significant protein-protein interactions with important hub genes (NR3C1, HIF1A, PPARG, MTOR, NOS3, SERPINE1, FLT1, PLAT, MAPK1, and LGALS3) involved in oxidative stress regulation, inflammatory management, and hormone balancing were found by network pharmacology analysis using Cytoscape and STRING.
Results
Important pathways like Type II diabetes mellitus, HIF-1 signaling, thyroid hormone signaling, and PI3K-Akt signaling were found using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) pathway enrichment analyses. Strong binding affinities were shown by molecular docking, especially for riboflavin with PPARG (-8.2 kcal/mol) and ascorbic acid with HIF1A (-6.6 kcal/mol), indicating possible roles in the treatment of PCOS.
Conclusion
The data analysis from the study suggests Spirulina Plantesis natural dietary food supplement, for PCOS adjunctive treatment. Although phytochemicals produced from SP present a prospective substitute for traditional PCOS treatments, additional in vitro, in vivo, and clinical research is necessary to confirm their effectiveness.
Zitieren
APA
Gabhane, V., Gupta, K. R., Khona, P. J., & Umekar, M. J. (2026). Exploring the therapeutic potential of Spirulina platensis in polycystic ovarian syndrome: A computational pharmacology approach. In Silico Research in Biomedicine, 2, 100240. https://doi.org/10.1016/j.insi.2026.100240
Vancouver
Gabhane V, Gupta KR, Khona PJ, Umekar MJ. Exploring the therapeutic potential of Spirulina platensis in polycystic ovarian syndrome: A computational pharmacology approach. In Silico Research in Biomedicine. 2026;2:100240. doi:10.1016/j.insi.2026.100240
BibTeX
@article{Gabhane2026,
author = {Gabhane, Vaishnavi and Gupta, Krishna Radheshyam and Khona, Pratik J and Umekar, Milind Janrao},
title = {Exploring the therapeutic potential of Spirulina platensis in polycystic ovarian syndrome: A computational pharmacology approach},
journal = {In Silico Research in Biomedicine},
year = {2026},
volume = {2},
pages = {100240},
doi = {10.1016/j.insi.2026.100240}
}
EUVIMED